Back to Authors

Guan, Xuesong

Mayo Clinic

Pfizer (United States)

Citations 1

MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer
Bekaii‐Saab, Tanios , Cercek, Andrea , Heinemann, Volker , Raghav, Kanwal Pratap Singh, Yoshino, Takayuki, Ramos, Jorge , Guan, Xuesong, André, Thierry , Bekaii-Saab, Tanios S , Strickler, John H. , Nakamura, Yoshiaki, Siena, Salvatore , Tabernero, Josep , Cutsem, Eric Van , Yoshino, Takayuki , André, Thierry

Future Oncology | December 26, 2024 | Volume: 21 | Issue: 3 | Pages: 303-311

10.1080/14796694.2024.2441101 Get It